STENVIZY Trademark

Trademark Overview

On Thursday, February 17, 2022, a trademark application was filed for STENVIZY with the United States Patent and Trademark Office. The USPTO has given the STENVIZY trademark a serial number of 97271346. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2024. This trademark is owned by Beigene, Ltd.. The STENVIZY trademark is filed in the Pharmaceutical Products category with the following description:

Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
stenvizy

General Information

Serial Number97271346
Word MarkSTENVIZY
Filing DateThursday, February 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesMedicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeigene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeigene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404

Trademark Events

Event DateEvent Description
Monday, February 21, 2022NEW APPLICATION ENTERED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 2, 2022ASSIGNED TO EXAMINER
Friday, December 2, 2022NON-FINAL ACTION WRITTEN
Friday, December 2, 2022NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 10, 2023SOU EXTENSION 1 FILED
Wednesday, May 10, 2023SOU EXTENSION 1 GRANTED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU EXTENSION 2 FILED
Tuesday, February 27, 2024SOU EXTENSION 2 GRANTED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

stenvizy preparations purposes medical diseases treatment cancer pharmaceutical pharmaceuticals reagents autoimmune